Cargando…

Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure–activity relationships

Glycyrrhizic acid (18β-GL or GL) is a herbal drug with a broad spectrum of antiviral activities and pharmacological effects and multiple sites of action. Previously we showed that GL inhibits Epstein-Barr virus (EBV) infection in vitro by interfering with an early step of the EBV replication cycle (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jung-Chung, Cherng, Jaw-Ming, Hung, Man-Shan, Baltina, Lidia A., Baltina, Lia, Kondratenko, Rimma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114209/ https://www.ncbi.nlm.nih.gov/pubmed/18423902 http://dx.doi.org/10.1016/j.antiviral.2008.01.160

Ejemplares similares

Synthesis of Glycyrrhizic Acid Conjugates with S-Benzyl-L-Cysteine and Their Antiviral Activity
por: Baltina, L. A., et al.
Publicado: (2021)

1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide in the Synthesis of Glycyrrhizic Acid Amino-Acid Conjugates
por: Baltina, L. A., et al.
Publicado: (2020)

Synthesis and biological activity of new glycyrrhizic acid conjugates with amino acids and dipeptides
por: Baltina, L. A., et al.
Publicado: (2009)

Synthesis and antiviral activity of 18α-glycyrrhizic acid and its esters
por: Baltina, L. A., et al.
Publicado: (2010)

Glycyrrhizic acid derivatives as Dengue virus inhibitors
por: Baltina, Lidia A., et al.
Publicado: (2019)

Synthesis and anti-HIV-1 activity of new conjugates of 18β- and 18α-glycyrrhizic acids with aspartic acid esters
por: Baltina, L. A., et al.
Publicado: (2012)

Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)
por: Baltina, L. A., et al.
Publicado: (2010)

Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors
por: Baltina, Lidia A., et al.
Publicado: (2015)

Synthesis of amino acid conjugates of glycyrrhizic acid using N-hydroxyphthalimide and N,N'-dicyclohexylcarbodiimide
por: Baltina, L. A., et al.
Publicado: (2016)

Synthesis of Glycyrrhizic Acid Conjugates with Amino-Acid Methyl Esters and their Ability to Stimulate Antibody Genesis in Mice
por: Baltina, L. A., et al.
Publicado: (2022)

Synthesis and antiviral activity of novel glycyrrhizic acid conjugates with D-amino acid esters
por: Fayrushina, A. I., et al.
Publicado: (2017)

Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity
por: Hour, Mann-Jen, et al.
Publicado: (2022)

Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
por: Bentz, Gretchen L., et al.
Publicado: (2019)

Synthesis and Anti-HIV-1 Activity of Olean-9(11),12(13)-Dien-30-Oic Acid 3β-(2-O-β-D-Glucuronopyranosyl-β-D-Glucuronopyranoside)
por: Baltina, L. A., et al.
Publicado: (2014)

Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome
por: Lin, Jung-Chung, et al.
Publicado: (2009)

New method of preparation of carboxy-protected amino acid conjugates of glycyrrhizinic acid
por: Baltina, L. A., et al.
Publicado: (2016)

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
por: Yiu, Ching-Yi, et al.
Publicado: (2010)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2
por: Yu, Shaopeng, et al.
Publicado: (2021)

Some recent developments in the molecular epidemiology of Epstein-Barr virus infections.
por: Miller, G., et al.
Publicado: (1987)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Discussion of Some Recent Developments in the Molecular Epidemiology of Epstein-Barr Virus Infections
por: Evans, Alfred S.
Publicado: (1987)

Detection of Epstein-Barr virus in recurrent tonsillitis
por: Dias, Eliane Pedra, et al.
Publicado: (2015)

Outcomes after arthroscopic revision surgery for anterior cruciate ligament injuries
por: Yumashev, Alexei V, et al.
Publicado: (2021)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

Possible roles of Epstein-Barr virus in Castleman disease
por: Chen, Chih-Hao, et al.
Publicado: (2009)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Plasma Macrophage Inhibitory Cytokine-1 as a Complement of Epstein-Barr Virus Related Markers in Identifying Nasopharyngeal Carcinoma
por: Xing, Shan, et al.
Publicado: (2020)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
por: Münz, Christian
Publicado: (2020)

Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice
por: Münz, Christian
Publicado: (2019)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_angilrbeakmscudg5gq0ebik70